Skip to main content

Table 3 Use of iodine-containing supplements and pregnancy and birth outcomes

From: Insufficient maternal iodine intake is associated with subfecundity, reduced foetal growth, and adverse pregnancy outcomes in the Norwegian Mother, Father and Child Cohort Study

 

Number

Crude models

 

Adjusted modelsa

 

Restricted controlsb

  

Odds ratio (95% CI)

p value

Odds ratio (95% CI)

p value

Odds ratio (95% CI)

Intrauterine death

270/78,318 (0.34%)

     

 Any iodine supplement use GW 0–20

29,131

0.80 (0.62, 1.03)

0.089

0.78 (0.61, 1.02)

0.071

0.96 (0.64, 1.45)

 First report of iodine supplement

  Never (non-supplement user)

49,187 (13,451b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7477

0.79 (0.51, 1.23)

0.30

0.76 (0.48 1.19)

0.23

0.92 (0.53, 1.62)

  GW 0–12

7149

0.94 (0.62, 1.42)

0.77

0.92 (0.60, 1.40)

0.70

1.11 (0.63, 1.94)

  GW > 12

5253

0.77 (0.45, 1.30)

0.32

0.76 (0.45, 1.29)

0.31

0.78 (0.38, 1.60)

Preeclampsia

2936/78,318 (3.8%)

     

 Any iodine supplement use GW 0–20

29,131

0.98 (0.91, 1.06)

0.64

0.93 (0.86, 1.01)

0.098

0.94 (0.84, 1.06)

 First report of iodine supplement

  Never (non-supplement user)

49,187 (13,451b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7477

0.88 (0.77, 1.01)

0.067

0.85 (0.74, 0.98)

0.022

0.84 (0.71, 1.00)

  GW 0–12

7149

1.05 (0.92, 1.19)

0.48

0.96 (0.84, 1.10)

0.58

0.97 (0.82, 1.14)

  GW > 12

5253

0.99 (0.86, 1.15)

0.93

0.93 (0.80, 1.08)

0.35

0.91 (0.76, 1.11)

Preterm delivery (< GW 37)

3889/77,995 (5.0%)

     

 Any iodine supplement use GW 0–20

29,014

1.00 (0.93, 1.07)

0.98

0.97 (0.91, 1.04)

0.42

1.07 (0.96, 1.18)

 First report of iodine supplement

      

  Never (non-supplement user)

48,981 (13,405b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7445

1.07 (0.96, 1.20)

0.21

1.05 (0.94, 1.18)

0.35

1.18 (1.03, 1.36)

  GW 0–12

7126

1.02 (0.91, 1.14)

0.70

0.99 (0.88, 1.11)

0.82

1.08 (0.94, 1.25)

  GW > 12

5230

1.02 (0.90, 1.17)

0.71

0.99 (0.87, 1.13)

0.86

1.04 (0.89, 1.23)

Early preterm delivery (< GW 32)

612/77,995 (0.78%)

     

 Any iodine supplement use GW 0–20

29,014

0.82 (0.69, 0.97)

0.020

0.80 (0.67, 0.95)

0.010

0.82 (0.64, 1.05)

 First report of iodine supplement

  Never (non-supplement user)

48,981 (13,405b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7445

0.94 (0.72,1.24)

0.67

0.94 (0.71, 1.24)

0.66

0.98 (0.71, 1.38)

  GW 0–12

7126

0.83 (0.62,1.12)

0.22

0.80 (0.60, 1.08)

0.14

0.73 (0.51, 1.08)

  GW > 12

5230

0.61 (0.41, 0.90)

0.014

0.59 (0.40, 0.87)

0.008

0.62 (0.39, 0.98)

Spontaneous preterm delivery (< GW 37)

2211/76,313 (2.8%)

     

 Any iodine supplement use GW 0–20

28,406

1.03 (0.95, 1.13)

0.45

1.00 (0.91, 1.09)

0.93

1.09 (0.95, 1.25)

 First report of iodine supplement

  Never (non-supplement user)

47,907 (13,196b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7273

1.08 (0.94, 1.25)

0.28

1.07 (0.92, 1.24)

0.39

1.20 (1.00, 1.44)

  GW 0–12

6977

1.08 (0.93, 1.25)

0.31

1.02 (0.88, 1.19)

0.75

1.12 (0.93, 1.35)

  GW > 12

5123

1.09 (0.93, 1.29)

0.29

1.04 (0.88, 1.23)

0.65

1.12 (0.91, 1.38)

  

Beta (95% CI)

 

Beta (95% CI)

 

Beta (95% CI)

Birth weight

78,210

     

 Any iodine supplement use GW 0–20

29,091

− 11.0 (− 19.4, − 2.7)

0.009

13.6 (5.6, 21.7)

0.001

3.3 (−8.3, 14.8)

 First report of iodine supplement

  Never (non-supplement user)

49,119 (13,435b)

0 (ref.)

 

0 (ref.)

 

0 (ref.)

  Before pregnancyc

7462

− 5.1 (− 19.1, 8.9)

0.48

16.3 (2.7, 29.9)

0.019

7.5 (− 9.0, 23.9)

  GW 0–12

7139

− 12.4 (− 26.4, 1.6)

0.084

19.6 (6.0, 33.1)

0.005

9.7 (− 6.8, 26.2)

  GW > 12

5248

− 11.7 (− 27.7, 4.3)

0.15

16.8 (1.4, 32.2)

0.033

12.0 (− 6.5, 30.4)

Birth weightz-score

77,949

     

 Any iodine supplement use GW 0–20

28,998

− 0.03 (− 0.04, −  0.01)

0.001

0.03 (0.01, 0.04)

< 0.001

0.01 (− 0.01, 0.03)

 First report of iodine supplement

  Never (non-supplement user)

48,951 (13,393b)

0 (ref.)

 

0 (ref.)

 

0 (ref.)

  Before pregnancyc

7439

0.00 (−0.02, 0.03)

0.88

0.05 (0.03, 0.07)

< 0.001

0.04 (0.01, 0.07)

  GW 0–12

7121

− 0.03 (− 0.05, − 0.00)

0.043

0.04 (0.02, 0.07)

< 0.001

0.03 (0.00, 0.06)

  GW > 12

5229

− 0.04 (− 0.07, − 0.02)

0.002

0.02 (− 0.01, 0.05)

0.13

0.01 (− 0.02, 0.05)

  

Odds ratio (95% CI)

 

Odds ratio (95% CI)

 

Odds ratio (95% CI)

SGA

7637/77,949 (9.8%)

     

 Any iodine supplement use GW 0–20

28,998

1.01 (0.96, 1.06)

0.83

0.91 (0.87, 0.96)

< 0.001

0.95 (0.88, 1.02)

 First report of iodine supplement

  Never (non-supplement user)

48,951 (13,393b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7439

0.97 (0.89, 1.06)

0.49

0.89 (0.82, 0.97)

0.009

0.91 (0.82, 1.01)

  GW 0–12

7121

0.98 (0.90, 1.07)

0.70

0.88 (0.80, 0.95)

0.003

0.91 (0.82, 1.02)

  GW > 12

5229

1.04 (0.94, 1.14)

0.44

0.93 (0.84, 1.02)

0.139

0.95 (0.85, 1.07)

LGA

7539/77,949 (9.7%)

     

 Any iodine supplement use GW 0–20

28,998

0.92 (0.88, 0.97)

0.002

1.03 (0.98, 1.08)

0.31

1.02 (0.95, 1.10)

 First report of iodine supplement

  Never (non-supplement user)

48,951 (13,393b)

1 (ref.)

 

1 (ref.)

 

1 (ref.)

  Before pregnancyc

7439

1.00 (0.92, 1.08)

0.92

1.10 (1.01, 1.19)

0.034

1.08 (0.97, 1.19)

  GW 0–12

7121

0.89 (0.82, 0.97)

0.011

1.03 (0.94, 1.12)

0.57

1.02 (0.92, 1.14)

  GW > 12

5229

0.88 (0.80, 0.97)

0.014

1.01 (0.91, 1.12)

0.89

1.01 (0.90, 1.14)

  1. aModels were adjusted for maternal age, BMI, parity, education, smoking in pregnancy, fibre intake, chronic illness, in vitro fertilization, folic acid supplement within the interval from 4 weeks before to 8 weeks after conception (only for intrauterine death), child sex (only for unstandardized birth weight), and vitamin D (only for preeclampsia)
  2. bAdjusted associations restricting the reference group (non-users) to participants who reported use of one or more multivitamin/multimineral supplements in the food frequency questionnaire, but not any containing iodine
  3. cOne to 26 weeks before conception